|
Drugs |
Rasa |
Guna |
Veerya |
Vipaka |
Karma |
DoshaGh
anata |
Abhaya (Haritaki) |
Madhura Amla Katu Tikta Kashaya |
Guru |
Ushna |
Madhura |
Vatanulom ana, Arshoghna |
Tridoshag hna |
Guda |
Madhura |
Guru Snighda |
Sheeta |
Madhura |
Dipaniya Pachaniya |
Vatahara |
PREVIOUS
RESEARCH WOR KS
1.
PATTANSHETTI
SNEHA and Y. M Santosh, (Dissertation submitted to KLE university) 2018 evaluated that Bhallatakadi Modaka (Study group) show
significant result in Reduced appetite, Straning effects and Bleeding per anus
in the Management of Arsha W.S.R to 1st and 2nd Degree Haemorrhoids at dose of
2 TID (500mg each tablet) when given for 7 days but there is less difference in
the improvement of reduced appetite comparing other two assessment criteria 14 .
2.
SHANKAR
SANTOSH and Rao P.N, (Dissertation Submitted to the Rajiv
Gandhi University of Health Sciences, Karnataka, Bengaluru) 2018 evaluated that Bhallatakadi Modaka (study group) show
significant result in Reduce pain and burning sensation in the Management of Pittaja Arsha ( Haemorrhoids) at dose of
2gm twice a day when given for 15 days whereas constipation still persisted and
in the Control group ( Arshakuthar rasa)
no much reduction was noticed in the same features15 .
«
To study the efficacy of Gudabhaya
in Arsha W.S.R 1st and
2nd degree haemorrhoids.
1.
To evaluate the efficacy of Gudabhaya in the management of Arsha
W.S.R 1st and 2nd
degree haemorrhoids.
2.
To compare the efficacy of Gudabhaya
over Arshakuthara Rasa in the management of
Arsha W.S.R 1st and 2nd degree haemorrhoids.
H0:
Gudabhaya
is
not effective in
the management of Arsha W.S.R 1st
and 2nd degree
haemorrhoids.
H1:
Gudabhaya
is effective in the management of
Arsha W.S.R 1st and 2nd
degree haemorrhoids.
Whether Gudabhaya is
significantly effective in the management of Arsha W.S.R 1st and 2nd degree haemorrhoids
or not when administered for 15 days?
SOURCE OF DATA: The
source of the data for the present
study will be taken from classical
texts, modern books, research articles, journals and internet.
•
Abhaya and Guda powder will be procured from GMP
certified KLE Ayurveda Pharmacy, Khasbag, Belagavi.
•
Abhaya powder will be prepared
at GMP certified KLE Ayurveda
Pharmacy, Khasbag, Belagavi.
•
Control drug will be procured from GMP certified KLE Ayurveda Pharmacy, Khasbag, Belagavi.
SUBJECTS: The
patients with age between 18 to 75 years of either sex will be taken for the
study from OPD of KLE Ayurved Hospital
and Meddical Research
Centre,Shahapur, Belagavi.
•
Gudabhaya6 (Trial drug)
•
Arshakuthara
Rasa 16(Control drug)
•
Authentication of raw drugs will be done by experts,
in the AYUSH Approved drug testing laboratory CRF, KAHER’s Shri B.M.K Ayurveda
Mahavidyalaya, Shahapur, Belagavi.
•
Analytical study of finished product will be carried
out in the AYUSH Approved drug
testing laboratory, CRF, KAHER’s Shri B.M.K Ayurveda Mahavidyalaya, Shahapur,
Belagavi.
Method of Preparation of Gudabhaya
1. Abhaya Choorna– 1 part
2. Guda –
2 parts
2. Preparation of Gudabhaya
•
One part of dry fruit of Abhaya (Haritaki) is taken and made into fine powder
•
The fine powder will be sieved.
•
All particles should pass through sieve with a nominal mesh aperture of
180 micrometre.
•
Two parts of procured Guda powder
is taken and pounded well.
•
One part of
sieved Abhaya (Haritaki) powder and two parts of guda powder is mixed thoroughly.
•
Then 15 gms of mixed powdered drug is stored in a sterilized air tight container.
•
Avoiding direct exposure to sunlight and air.
Packaging will be done in GMP Certified KLE Ayurveda Pharmacy, Khasbag, Belagavi,
Karnataka and storage will be done in KLE Ayurveda Hospital and Medical
Research centre, Belagavi.
MAIN STUDY: CLINICAL STUDY
STUDY TYPE – Interventional
INTERVENTIONAL DRUG – Gudabhaya
STUDY DESIGN – Randomized Controlled Clinical Trial
MASKING - Open label
CONTROL - Standard
SAMPLE SIZE – 30
Patient will be selected by
computerized block randomization method
END POINT – Efficacy
of Gudabhaya in Arsha W.S.R 1st and 2nd degree haemorrhoids
when administered for 15 days.
Patient selected by
Randomization chart –
Group Name |
Description |
Sample size |
GROUP-A |
Trial group |
15 |
GROUP-B |
Control
group |
15 |
GROUPS AND
INTERVENTION INCLUDING FOLLOW UP:
NAME OF THE GROUP |
SAMPLE SIZE |
DRUGS |
DOSE AND DURATION |
FOLLOW UP |
GROUP A Trial Group |
15 |
Gudabhaya |
15 gm
twice a day |
7th
day and 15th day |
GROUP B Control Group |
15 |
Arshakuthar Rasa |
250 mg
twice a day |
7th
day and 15th day |
DIAGNOSTIC
CRITERIA
1. Constipation
2. Bleeding per Anus
3. Pile mass (by Proctoscopic examination)
4.
Kandu and vedana
5. Newly arisen Haemorrhoids
with less symptoms and complications5.
o
Patients with Arsha or
haemorrhoids (1st and 2nd degree)
o Age between 18-75 years
irrespective of gender.
o
Thrombosed Haemorrhoids, Prolapsed Haemorrhoids.
o
Haemorrhoids occurs with known secondary cause such as
portal HTN, liver cirrhosis, etc.
o
History of known case of Systemic Illness
like Carcinoma of Rectum, Inflammatory Bowel Diseases, DM, HIV I
& II, HbsAg.
The Principal
Investigator may stop your participation in the study at any time for one or
more of the following reasons.
1.
Any serious adverse events requiring major interventions.
2.
Any time during the study, continuation of study drug could lead to
harmful effect.
3.
Any untoward event where in investigator feels
continuation of trial may jeopardise the health state of the subject.
4.
Subjects failure to follow the instructions of the Principal Investigator.
5.
If patient needs treatment that are not allowed in the study.
6.
Other administrative reasons
Suitable, descriptive and inferential statistical tests will be
identified and applied for testing the hypothesis on consulting a statistician.
There may be significant effect of Gudabhaya
in the management Arsha w.s.r. 1st
and 2nd degree haemorrhoids when administered for 15 days.
Patients will be managed according to conventional line of treatment
depending on type of complaints.
Parameter |
Baseline |
7th Day |
15th Day |
Constipation |
|
|
|
Bleeding per
Anus |
|
|
|
No. of pile
mass |
|
|
|
Size of pile
mass |
|
|
|
STUDY DRUG DOSE : 15gm Twice a day 6.
STUDY SITE :
KLE Ayurveda Hospital and Medical Research centre,
Belagavi
STUDY PEROID : 18 months
ROUTE OF ADMINISTRATION: ORAL
Anupana- Sheeta Jala
Duration of treatment: 15 days
Assessment: Baseline, 7th& 15th day
SOP –Preparation of drug done as per SOP17, in KLE
Ayurveda Pharmacy, Belagavi.
Assessment will be done before
treatment and after treatment
1) Constipation
1) Bleeding per anus
2) Number of pile mass
3) Degree of hemorrhoidal
prolapse
1) Constipation: ROME III diagnostic
criteria for functional gastro intestinal disorders18.
Q. Straining during at least 25%
of defecations
Grade 0 Never
Grade 1 Less
than once Week
Grade 2 1–
6 Times/week
Grade 3 Every
Day
1)
Bleeding per Anus
G1- Nil
G2- Mild; occasional episodes (during
defecation) G3- Moderate;
frequent episodes (during defecation)
G4- Severe;
persistent bleeding even without defecation with fall in Hb level (<10 gm/dL); requiring hematinics.
G5- Very severe;
bleeding in the form of jets and splashes with severe fall in Hb
level (<7 gm/dL); requiring blood
transfusion.
G1 - None
G2- One
G3- Two
G4- Three
G5- Circumferential (presence of
secondary hemorrhoids along with the involvement of all primary hemorrhoids)
G1- No hemorrhoidal prolapse
G2- Prolapse upon straining that reduces
spontaneously G3- Prolapse upon straining that needs manual reduction
G4- Prolapsed and irreducible
hemorrhoids but without ischemic changes.
G5- Prolapsed and irreducible
hemorrhoids with ischemic (gangrenous) changes.
BMK/20/PG/ST/4
Yet to be registered
1.
Das.S, A
CONCISE TEXTBOOK OF SURGERY, 6th ed. Kolkata: Old Mayors’ Court; 2010, Chapter 46. P -969
2.
Gandagi N. ,Patil
S.,The Medical Management of Arsha with Chirabilwadi Quatha and
Kaseesadi Thaila Sthanika Abhyanga, 2015 Vol
6 No 2 ISSN:0976- 5921 https://doi.org/10.47552/ijam.v6i2.574
3.
Bhat S. SRB’s.Manual of surgery ,5th ed.: jaypee publication
2017.Chapter 25, p .971.
4.
Nan AK. Undergraduate Surgery. 3rd ed. CBS publisher.2016, Chapter 50, p.566.
5.
Trikamji
J,editor, ( ed. reprint). Sushruta
Samhita of Sushruta, Chikitsha sthana; Arshasam chikitsitam: Chapter 6, Verse 3. Varansi: Chaukhamba Sanskrit Sansthan,2019;430
6.
Mishra S, Bhaishaja
Ratnavali,Sidhi prada Hindivyakhyan Chapter 9,Verse 23, Chaukamba
Surabharti prakashan ,Varanasi.2014; 311
7.
Bhat S. SRB’s.Manual of surgery ,5th ed.: jaypee publication 2017,
Chapter 25.p .969
8.
Dvivedi BK
and goswami p editor; Charak Samhita edited
with Ayurveda tattvasandipika,Chikitsa Sthana, ChikitsitamAdhyaya, Chapter 14, Verse 147, Chaukambha krishandas
academy Sanskrit , Varanasi Reprint 2016.
9.
Trikamji
J,editor, ( ed. reprint ). Sushruta
Samhita of SushrutaNidanasthana;;
Arshasamnidanam: Chapter 2,.Varansi:
Chaukhamba Sanskrit Sansthan,, 2019;
10.
Upadhyaya
V, (ed. reprint) Astanga Hruday of Vagbhata, Nidanasthana; Arsha Nidana Adhyaya: Chapter 7.
Varanasi: ChaukhambhaSurbhartiPrakashan, 2019
11.
Trikamji J,editor, (ed. reprint). Sushruta Samhita of Sushruta,
Sutra sthana; AvaraniyamAdhyaya: Chapter 33, Verse 4. Varansi: Chaukhamba
Sanskrit Sansthan,, 2019;144.
12.
Trikamji J,editor, ( ed. reprint). Sushruta Samhita of Sushruta, Chikitsha sthana;
Arshasam chikitsitam: Chapter 6, Verse 3. Varansi: Chaukhamba Sanskrit
Sansthan,, 2019;430
13.
.Dvivedi BK and goswami p (ed. Reprint); Charak Samhita edited with Ayurveda
tattvasandipika,Chikitsa Sthana, ChikitsitamAdhyaya, Chapter 14, Verse 6,
Chaukambha krishandas academy Sanskrit , Varanasi 2016. P.470.
14.
Pattanshetti S et al 2018 evaluated the ‘Effect of Bhallatakadi modaka in the Management of Arsha W.S.R to 1st and 2nd Degree
Haemorrhoids ’ KAHER Shri BMK
, belagavi,2018 -19.
15.
Shankar S -
et al 2018 evaluate “A Clinical Study of Bhallatakadi
modaka in the Management of Pittaja Arsha(Haemorrhoids) ‘SDM hassan’,2018-19.
16.
Mishra S edi. ,Bhaishaja Ratnavali,Sidhi prada Hindivyakhyan
Chapter 9,Verse 238, Chaukamba Surabharti prakashan ,Varanasi.2014; 330
17.
The Ayurvedic Pharmacopia of India Part -1 Volume
8,First edition .27th Monograph page no.82.
18.
DOUGLAS Drossman.GastroenterologyVol 130 No.5, Rome
III Diagnostic Criteria For Functional
19.
PNR-Bleed†classification and Hemorrhoid Severity
Score, Journal of Coloproctology, j
coloproctol (rio j). 2 0 2 0;40(4):398–403 https://jcol.elsevier.es/en-pnrbleed-
classification-hemorrhoid-severity-scorea-articulo-S2237936320300423